The aim of this study was to demonstrate the relationship between the PLA2R1 and HLA-DQA1 genes and PMN and to determine the clinical value of SNP in the treatment of primary membranous nephropathy. The gene discussed is HLA-DQA1; the disease is membranous glomerulonephritis.